ID: ALA5273566

Max Phase: Preclinical

Molecular Formula: C22H21F3N6O2

Molecular Weight: 458.44

Associated Items:

Representations

Canonical SMILES:  CN1CCN(c2ccc(Nc3nccc(-c4ccc([N+](=O)[O-])cc4)n3)cc2C(F)(F)F)CC1

Standard InChI:  InChI=1S/C22H21F3N6O2/c1-29-10-12-30(13-11-29)20-7-4-16(14-18(20)22(23,24)25)27-21-26-9-8-19(28-21)15-2-5-17(6-3-15)31(32)33/h2-9,14H,10-13H2,1H3,(H,26,27,28)

Standard InChI Key:  PCZLHHXHFHLORK-UHFFFAOYSA-N

Associated Targets(Human)

CDK2 Tchem Cyclin-dependent kinase 2/cyclin A (2220 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

pknB Serine/threonine-protein kinase pknB (356 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 458.44Molecular Weight (Monoisotopic): 458.1678AlogP: 4.57#Rotatable Bonds: 5
Polar Surface Area: 87.43Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.66CX LogP: 4.97CX LogD: 4.52
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.44Np Likeness Score: -1.71

References

1. Wlodarchak N, Feltenberger JB, Ye Z, Beczkiewicz J, Procknow R, Yan G, King TM, Golden JE, Striker R..  (2021)  Engineering Selectivity for Reduced Toxicity of Bacterial Kinase Inhibitors Using Structure-Guided Medicinal Chemistry.,  12  (2.0): [PMID:35035774] [10.1021/acsmedchemlett.0c00580]

Source